Vessel Due F soft capsules are indicated for:
- angiopathy with an increased risk of thrombosis, including after myocardial infarction;
- Cerebrovascular disorders, including the acute period of ischemic stroke and the early recovery period; dyscirculatory encephalopathy caused by atherosclerosis, diabetes mellitus, hypertension; vascular dementia
- occlusive lesions of peripheral arteries of both atherosclerotic and diabetic genesis;
- phlebopathy, deep vein thrombosis;
- microangiopathy (nephropathy, retinopathy, neuropathy) and macroangiopathy in diabetes mellitus (diabetic foot syndrome, encephalopathy, cardiopathy);
- thrombotic conditions, antiphospholipid syndrome (prescribed simultaneously with acetylsalicylic acid).
Composition
Active ingredient: sulodexide;
1 capsule contains 250 LO (lipoprotein lipase units) sulodexide;
Excipients: sodium lauryl sarcosinate, colloidal silicon dioxide, triacetin, gelatin, glycerin, sodium ethyl parahydroxybenzoate (E 215), sodium propyl parahydroxybenzoate (E 217), titanium dioxide (E 171), red iron oxide (E 172).
Contraindication
- hypersensitivity to the components of the drug;
- hemorrhagic diatheses and diseases accompanied by reduced blood clotting;
- pregnancy in the first trimester.
Method of application
1 capsule 2 times a day inside between meals for 30-40 days. The maximum single dose is 4 capsules, daily dose – 8 capsules. The full course of treatment should be repeated at least 2 times a year. In case of exacerbation of the disease or severe course, treatment should be started with parenteral administration of Vessel Due F, and then continue with taking capsules for 20-40 days.
Application features
Pregnant women
Since there is no experience with the use of the drug in the first trimester of pregnancy, the drug should be avoided in women during this period, except in cases where, in the opinion of the doctor, the expected benefit of treatment for the mother outweighs the possible risk to the fetus.
Children
From the age of 12.
Drivers
No effect.
Overdose
Overdose of the drug may lead to the development of hemorrhagic symptoms, such as hemorrhagic diathesis or bleeding. In case of bleeding, a 1% solution of protamine sulfate should be administered. In general, in case of overdose, the drug should be discontinued and appropriate symptomatic therapy should be initiated.
Side effects
- nausea, vomiting, epigastric pain;
- skin rash (allergic reaction).
Interaction
Since sulodexide is a heparin-like molecule, when used simultaneously it may increase the anticoagulant effect of heparin and oral anticoagulants. No other clinically significant drug interactions have been identified.
Storage conditions
Store at a temperature not exceeding 30 °C.
Keep out of reach of children.
Shelf life – 5 years.











Reviews
There are no reviews yet.